Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Incyte Corporation - Common Stock (NQ:INCY)

85.25 +0.33 (+0.39%)
Streaming Delayed Price Updated: 12:42 PM EDT, Aug 19, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 452,070
Open 84.94
Bid (Size) 85.25 (1)
Ask (Size) 85.31 (1)
Prev. Close 84.92
Today's Range 84.55 - 85.42
52wk Range 53.56 - 87.24
Shares Outstanding 222,430,635
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Incyte to Present at Upcoming Investor Conferences
From Incyte
Via Business Wire
Immuno-Oncology Stocks Q2 In Review: Incyte (NASDAQ:INCY) Vs Peers
As the Q2 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the immuno-oncology industry, including Incyte (NASDAQ:INCY) and its peers. 
Via StockStory
Topics Artificial Intelligence

Performance

YTD
+22.6%
+22.6%
1 Month
+26.5%
+26.5%
3 Month
+33.6%
+33.6%
6 Month
+19.6%
+19.6%
1 Year
+34.8%
+34.8%

More News

Read More
Sotera Health Company, Incyte, Exact Sciences, Bausch + Lomb, and Addus HomeCare Shares Skyrocket, What You Need To Know
Via StockStory
Topics Economy Lawsuit
Barclays Initiates Incyte With Overweight Rating, $90 Price Target, Retail Finds Reason To Cheer
Via Stocktwits
Earnings Scheduled For July 29, 2025
Via Benzinga
A Look at Incyte's Upcoming Earnings Report
Via Benzinga
INCY Q2 Deep Dive: Product Launches and Pipeline Progress Underpin Revenue Growth
Via StockStory
1 Momentum Stock for Long-Term Investors and 2 Facing Challenges
Via StockStory
Beyond The Numbers: 12 Analysts Discuss Incyte Stock
Via Benzinga
Incyte Announces Departure of Chief Financial Officer Christiana Stamoulis
From Incyte
Via Business Wire
Incyte Corp (NASDAQ:INCY): A Value Investing Gem with Strong Valuation and Financial Stability
Via Chartmill
Gilead Sciences Reports Earnings Thursday. Can The Highly Ranked Drugmaker Beat Its 237% Profit Surge Last Quarter?
Via Investor's Business Daily
This Incyte Analyst Begins Coverage On A Bullish Note; Here Are Top 2 Initiations For Friday
Via Benzinga
The Analyst Verdict: Incyte In The Eyes Of 10 Experts
Via Benzinga
Top S&P500 movers in Tuesday's session
Via Chartmill
Incyte (INCY) Stock Trades Up, Here Is Why
Via StockStory
Topics Artificial Intelligence
Uncover the latest developments among S&P500 stocks in today's session.
Via Chartmill
Incyte Surges Past Expectations With Strong Q2, Boosts Guidance On Jakafi Demand
Via Benzinga
AMD Rises To 1-Year Highs, Crude Eyes $68: What's Moving Markets Tuesday?
Via Benzinga
Sanmina, Sarepta Therapeutics, Polaris, Celestica And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
Which S&P500 stocks are moving before the opening bell on Tuesday?
Via Chartmill
Incyte (NASDAQ:INCY) Reports Strong Q2
Via StockStory
Incyte Reports 2025 Second Quarter Financial Results and Provides Updates on Key Clinical Programs
From Incyte
Via Business Wire
Incyte (INCY) Q2 Earnings: What To Expect
Via StockStory
Topics Artificial Intelligence
Incyte To Present Initial Data for its TGFβR2×PD-1-directed Bispecific Antibody (INCA33890) and its Selective Inhibitor of G12D-mutated KRAS (INCB161734) at the European Society of Medical Oncology (ESMO) Congress 2025
From Incyte
Via Business Wire

Frequently Asked Questions

Is Incyte Corporation - Common Stock publicly traded?
Yes, Incyte Corporation - Common Stock is publicly traded.
What exchange does Incyte Corporation - Common Stock trade on?
Incyte Corporation - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Incyte Corporation - Common Stock?
The ticker symbol for Incyte Corporation - Common Stock is INCY on the Nasdaq Stock Market
What is the current price of Incyte Corporation - Common Stock?
The current price of Incyte Corporation - Common Stock is 85.25
When was Incyte Corporation - Common Stock last traded?
The last trade of Incyte Corporation - Common Stock was at 08/19/25 12:42 PM ET
What is the market capitalization of Incyte Corporation - Common Stock?
The market capitalization of Incyte Corporation - Common Stock is 18.96B
How many shares of Incyte Corporation - Common Stock are outstanding?
Incyte Corporation - Common Stock has 19B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.